Diphen and Cleocin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Cleocin (clindamycin phosphate). Common drug interactions include hypoxia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Diphen and Cleocin. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.
What is Diphen?
Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.
What is Cleocin?
Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,940 Cleocin users. Check the latest studies of Cleocin.
92 people who take Diphen and Cleocin together, and have interactions are studied.

What are the common drug interactions of Diphen and Cleocin, by gender? *:
female:
- Hypoxia (low oxygen in tissues)
- Intervertebral disc degeneration (spinal disc degeneration)
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Osteitis (a general term for inflammation of bone)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Rash
- Renal failure chronic (long lasting kidney dysfunction)
- Skin disorder (skin disease)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Spinal osteoarthritis (joint cartilage loss in spine)
male:
- Chronic kidney disease
- Proctalgia (pain in the rectum)
- Rectal abscess (pus in rectum)
- Septic shock (shock due to blood infection)
- Blood creatinine increased
- Diabetic complication
- Muscular weakness (muscle weakness)
- Pneumonia
- Pyrexia (fever)
- Seasonal allergy (allergic condition due to certain season)
What are the common drug interactions of Diphen and Cleocin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Ear pain
- Fatigue (feeling of tiredness)
- Gastric disorder (disease of stomach)
- Infusion site pain
- Infusion site scar
- Malaise (a feeling of general discomfort or uneasiness)
- Myalgia (muscle pain)
- Oropharyngeal pain
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Compulsive sexual behaviour (unable to manage his/her sexual behaviour)
- Compulsive shopping
- Disability
- Eating disorder
- Emotional distress
- Epistaxis (bleed from the nose)
- Impulse-control disorder
- Injury
40-49:
- Anxiety
- Depression
- Dizziness
- Fatigue (feeling of tiredness)
- Hypotension (abnormally low blood pressure)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Cellulitis (infection under the skin)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Blood glucose increased
- Contusion (a type of hematoma of tissue in which capillaries)
50-59:
- Respiratory disorder (respiratory disease)
- Sinusitis (inflammation of sinus)
- Vaginal infection
- Weight increased
- Folliculitis (infection of hair root)
- Injection site bruising
- Injection site erythema (redness at injection site)
- Kidney infection
- Leukaemia (blood or bone marrow cancer)
- Lymphadenopathy (disease or enlargement of lymph nodes)
60+:
- Proctalgia (pain in the rectum)
- Nausea (feeling of having an urge to vomit)
- Cellulitis (infection under the skin)
- Chronic kidney disease
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Hypertension (high blood pressure)
- Muscular weakness (muscle weakness)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Osteoporosis (bones weak and more likely to break)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 27 people, 29.35%
- Pain: 14 people, 15.22%
- Nausea (feeling of having an urge to vomit): 8 people, 8.70%
- Lung Cancer - Non-Small Cell (lung cancer): 8 people, 8.70%
- Nausea And Vomiting: 6 people, 6.52%
- High Blood Pressure: 6 people, 6.52%
- Rashes (redness): 5 people, 5.43%
* Approximation only. Some reports may have incomplete information.
Do you take Diphen and Cleocin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Diphen and Cleocin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Diphen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cleocin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Diphen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cleocin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on diphenhydramine hydrochloride and clindamycin phosphate (the active ingredients of Diphen and Cleocin, respectively), and Diphen and Cleocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hydramine cause Hyperkalemia? - 24 seconds ago
- Drug interactions of Starlix and Clopra - 26 seconds ago
- Could Spiriva Respimat cause Diabetes Mellitus Aggravated? - 37 seconds ago
- Could Fudr cause Nausea? - 41 seconds ago
- Could Primrose Oil cause Constipation? - 50 seconds ago
- Affective Disorder and Drug Withdrawal Syndrome - a minute ago
- Could Alcohol cause Wound? - a minute ago
- Could Polyethylene Glycol 3350 cause Urinary Retention? - a minute ago
- Drug interactions of Lamotrigine and Rivastigmine - a minute ago
- Drug interactions of Theophylline and Dutasteride - a minute ago